Anti-MMP9 antibody [EP1254] is a rabbit recombinant monoclonal antibody that is used to detect MMP9 in Flow cytometry (Intra), ICC/IF, IHC-P, Western blot. Suitable for Human, Rat, Recombinant fragment samples.
- Treatment increasing the expression of MMP-9 is recommended
- Using biophysical QC, antibody identity is confirmed at a molecular level for unrivaled batch-batch consistency
- Specificity and sensitivity confirmed in immunohistochemistry (IHC) with multi-tissue microarray (TMA) validation
- Cited in over 550 publications
pH: 7.2 - 7.4
Preservative: 0.01% Sodium azide
Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
IHC-P | WB | ICC/IF | Flow Cyt (Intra) | |
---|---|---|---|---|
Human | Tested | Tested | Tested | Tested |
Rat | Expected | Tested | Expected | Expected |
Recombinant full length protein - Human | Not recommended | Tested | Not recommended | Not recommended |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info 1/1000 | Notes For unpurified use at 1/100 - 1/250. Perform heat-mediated antigen retrieval before commencing with IHC staining protocol. |
Species | Dilution info | Notes |
---|---|---|
Species Rat | Dilution info Use at an assay dependent concentration. | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Recombinant full length protein - Human | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Recombinant full length protein - Human | Dilution info 1/1000 - 1/20000 | Notes Based on our preliminary data, ab76003 detects no or weak band of interest in the untreated cell lines at the dilution of 1/200. Treatment increasing the expression of MMP-9 is recommended when using this antibody. |
Species Rat | Dilution info 1/1000 - 1/20000 | Notes Based on our preliminary data, ab76003 detects no or weak band of interest in the untreated cell lines at the dilution of 1/200. Treatment increasing the expression of MMP-9 is recommended when using this antibody. |
Species Human | Dilution info 1/1000 - 1/20000 | Notes Based on our preliminary data, ab76003 detects no or weak band of interest in the untreated cell lines at the dilution of 1/200. Treatment increasing the expression of MMP-9 is recommended when using this antibody. |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info 1/250 - 1/500 | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Rat | Dilution info Use at an assay dependent concentration. | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Recombinant full length protein - Human | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info 1/1000 | Notes ab172730 - Rabbit monoclonal IgG, is suitable for use as an isotype control with this antibody. |
Species | Dilution info | Notes |
---|---|---|
Species Rat | Dilution info Use at an assay dependent concentration. | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Recombinant full length protein - Human | Dilution info - | Notes - |
Select an associated product type
Matrix metalloproteinase that plays an essential role in local proteolysis of the extracellular matrix and in leukocyte migration (PubMed:12879005, PubMed:1480034, PubMed:2551898). Could play a role in bone osteoclastic resorption (By similarity). Cleaves KiSS1 at a Gly-|-Leu bond (PubMed:12879005). Cleaves NINJ1 to generate the Secreted ninjurin-1 form (PubMed:32883094). Cleaves type IV and type V collagen into large C-terminal three quarter fragments and shorter N-terminal one quarter fragments (PubMed:1480034). Degrades fibronectin but not laminin or Pz-peptide.
CLG4B, MMP9, Matrix metalloproteinase-9, MMP-9, 92 kDa gelatinase, 92 kDa type IV collagenase, Gelatinase B, GELB
Anti-MMP9 antibody [EP1254] is a rabbit recombinant monoclonal antibody that is used to detect MMP9 in Flow cytometry (Intra), ICC/IF, IHC-P, Western blot. Suitable for Human, Rat, Recombinant fragment samples.
- Treatment increasing the expression of MMP-9 is recommended
- Using biophysical QC, antibody identity is confirmed at a molecular level for unrivaled batch-batch consistency
- Specificity and sensitivity confirmed in immunohistochemistry (IHC) with multi-tissue microarray (TMA) validation
- Cited in over 550 publications
pH: 7.2 - 7.4
Preservative: 0.01% Sodium azide
Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Based on our preliminary data, ab76003 detects no or weak band of interest in the untreated cell lines at the dilution of 1/200. Treatment increasing the expression of MMP-9 is recommended when using this antibody.
This antibody works better in 1% SDS Hot Lysates in WB. For Lysate preparation protocol, please refer to the protocol book in the protocol section and/or here (downloadable copy).
Mouse: We have internal testing data to indicate this antibody reacts with this species in immunohistochemical and ELISA-based applications, but we were unable to detect a band with mouse lysates in western blot. Please contact us for more information.
Product SpecificationsOur RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
This product is a recombinant monoclonal antibody, which offers several advantages including:
For more information, read more on recombinant antibodies.
We have tested this species and application combination and it works. It is covered by our product promise.
We have not tested this specific species and application combination in-house, but expect it will work. It is covered by our product promise.
This species and application combination has not been tested, but we predict it will work based on strong homology. However, this combination is not covered by our product promise.
We do not recommend this combination. It is not covered by our product promise.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
Blocking and diluting buffer and concentration: 5% NFDM/TBST.
Exposure time: 3 seconds; 40 seconds.
Anti-GAPDH antibody [EPR16891] - Loading Control ab181602 was used as loading control for GAPDH.
Although MMP9 has been studied in brain in some publications, ab76003 was unable to detect signal in normal brain tissue, this may because MMP9 expression level is low in normal brain and would be increased in abnormal conditions like injury (PMID: 31198417).
All lanes: Western blot - Anti-MMP9 antibody [EP1254] (ab76003) at 1/1000 dilution
Lane 1: Human lung tissue lysate at 20 µg
Lane 2: Human brain tissue lysate at 20 µg
Lane 3: Human spleen tissue lysate at 20 µg
Lane 4: Human lymph node tissue lysate at 20 µg
Lane 5: Rat lung tissue lysate at 20 µg
Lane 6: Rat brain tissue lysate at 20 µg
Lane 7: Rat spleen tissue lysate at 20 µg
Lane 8: Rat kidney tissue lysate at 20 µg
Lane 9: Rat lymph node tissue lysate at 20 µg
All lanes: Western blot - Goat Anti-Rabbit IgG H&L (HRP) (Goat Anti-Rabbit IgG H&L (HRP) ab97051) at 1/20000 dilution
Predicted band size: 29 kDa
MMP9 Western blot staining using rabbit Anti-MMP9 antibody
All lanes: Western blot - Anti-MMP9 antibody [EP1254] (ab76003) at 1/5000 dilution
Lanes 1 - 2: HTB94 (human chondrosarcoma cell line) cell lysate at 10 µg
Lanes 3 - 4: HTB94 (human chondrosarcoma cell line) conditioned media at 10 µg
All lanes: Goat anti-rabbit IgG at 1/5000 dilution
Developed using the ECL technique.
Predicted band size: 78 kDa
MMP9 Western blot staining using rabbit Anti-MMP9 antibody
This blot was produced using a 4-12% Bis-Tris gel under the MOPS buffer system. The gel was run at 200V for 60 minutes before being transferred onto a nitrocellulose membrane at 30V for 70 minutes. The membrane was then blocked for an hour before being incubated with anti-MMP9 antibody [EP1254] (ab76003; 5 microgram per mL) overnight at 4°C. Antibody binding was detected using infrared labeled goat anti-rabbit (green) antibody (diluted 1:20000) for 1 hour at room temperature before imaging.
Lanes 1 - 2: Western blot - Anti-MMP9 antibody [EP1254] (ab76003) at 5 µg
Lane 3: Western blot - Anti-MMP9 antibody [EP1254] (ab76003) at 5 µg/mL
Lane 1: Western blot - Native human MMP9 protein (dimer) (Native human MMP9 protein (dimer) ab168863) at 0.1 µg
Lane 2: Western blot - Native human MMP9 protein (Proenzyme, monomer) (Native human MMP9 protein (Proenzyme, monomer) ab157344) at 0.1 µg
Lane 3: Western blot - Recombinant Mouse MMP9 protein (Recombinant Mouse MMP9 protein ab39309) at 0.1 µg
All lanes: Infrared labeled goat anti-rabbit (green) antibody at 1/20000 dilution
Performed under reducing conditions.
Predicted band size: 78 kDa
Immunocytochemistry/Immunofluorescence analysis of U-2 OS (human osteosarcoma) cells labeling MMP9 with ab76003 at 1/500 (4.3 μg/mL). Cells were fixed with 4% paraformaldehyde and permeabilized with 0.1% Triton X-100. Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) ab150077, Alexa Fluor® 488-conjugated goat anti-rabbit IgG (1/1000, 2 μg/mL) was used as the secondary antibody. Cells were counterstained with Alexa Fluor® 594 Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker ab195889 Anti-Alpha Tubulin antibody [DM1A] (1/200, 2.5 μg/mL) - Microtubule Marker (Alexa Fluor® 594). DAPI (blue) was used as a nuclear counterstain.
Confocal image showing cytoplasmic staining onU-2 OS cells, the expression increased after treatment with TPA (200 nM) for 24 hours (middle panel).
Secondary Only Control: PBS was used instead of the primary antibody as the negative control with both TPA treated and untreated U-2 OS cells.
MMP9 Western blot staining using rabbit Anti-MMP9 antibody
Conditions: Denatured/reduced.
This blot was produced using a 4-12% Bis-Tris gel under the MOPS buffer system. The gel was run at 200V for 60 minutes before being transferred onto a nitrocellulose membrane at 30V for 70 minutes. The membrane was then blocked for an hour before being incubated with ab76003 (rabbit-anti MMP9; 1.5 ug/mL) and Anti-GAPDH antibody [6C5] - Loading Control ab8245 (loading control to GAPDH; 0.1 ug/mL) for 48 hours at 4°C. Before imaging, antibody binding was detected using infrared-labeled goat anti-rabbit (green) and goat anti-mouse (red) at 1:10,000 dilution for 1 hour at room temperature.
All lanes: Western blot - Anti-MMP9 antibody [EP1254] (ab76003) at 1.5 µg/mL
Lane 1: Control U937 at 100 µg
Lane 2: Stimulated U937 (24 hours with 10 ng x mL-1 PMA (Phorbol 12-myristate 13-acetate (PMA), PKC activator ab120297), 3 final hours with 3 ug x mL-1 of Brefeldin (Brefeldin A, Inhibitor of ADP-ribosylation factor ab120299)) at 100 µg
Lane 3: Human tonsils at 20 µg
All lanes: Goat anti-rabbit at 1/10000 dilution
Predicted band size: 78 kDa
Observed band size: 89 kDa
MMP9 Western blot staining using rabbit Anti-MMP9 antibody
Blocking and dilution buffer: 5% NFDM/TBST.
The expression of MMP-9 can be stimulated by various agents, such as inflammatory cytokine, growth factor, and 12-O-tetradecanoylphorbol-13-acetate (TPA) (PMID:21047770, 28969043).
Based on our preliminary data, ab76003 detects no or weak band of interest in the untreated cell lines at the dilution of 1/200. Treatment increasing the expression of MMP-9 is recommended when using this antibody.
All lanes: Western blot - Anti-MMP9 antibody [EP1254] (ab76003) at 1/200 dilution
Lane 1: LoVo (Human colorectal adenocarcinoma epithelial cell) whole cell lysate at 20 µg
Lane 2: Huh7 (Human hepatocellular carcinoma epithelial cell) whole cell lysate at 20 µg
Lane 3: MCF7 (Human breast adenocarcinoma epithelial cell) whole cell lysate at 20 µg
Lane 4: HeLa (Human cervix adenocarcinoma epithelial cell) whole cell lysate at 20 µg
Lane 5: Caco-2 (Human colorectal adenocarcinoma epithelial cell) whole cell lysate at 20 µg
Lane 6: A549 (Human lung carcinoma epithelial cell) serum starved overnight whole cell lysate at 20 µg
Lane 7: A549 (Human lung carcinoma epithelial cell) serum starved overnight, then treated with 80nM TPA for 24 hours whole cell lysate at 20 µg
Lane 8: MDA-MB-231 (Human breast adenocarcinoma epithelial cell) serum starved overnight whole cell lysate at 20 µg
Lane 9: MDA-MB-231 (Human breast adenocarcinoma epithelial cell) serum starved overnight, then treated with 200nM TPA for 24 hours whole cell lysate at 20 µg
Lane 10: HepG2 (Human hepatocellular carcinoma epithelial cell) whole cell lysate at 20 µg
All lanes: Western blot - Goat Anti-Rabbit IgG H&L (HRP) (Goat Anti-Rabbit IgG H&L (HRP) ab97051) at 1/20000 dilution
Predicted band size: 78 kDa
Observed band size: 84-82 kDa
Exposure time: 60s
MMP9 Western blot staining of Rat kidney tissue lysate using rabbit Anti-MMP9 antibody
Blocking and dilution buffer: 5% NFDM/TBST.
All lanes: Western blot - Anti-MMP9 antibody [EP1254] (ab76003) at 1/1000 dilution
All lanes: Rat kidney tissue lysate at 10 µg
All lanes: Peroxidase-conjugated goat anti-rabbit IgG, (H+L) at 1/1000 dilution
Predicted band size: 78 kDa
Observed band size: 84-92 kDa
Overlay histogram showing permeabilized A431 (Human epidermoid carcinoma cell line) cells stained with unpurified ab76003 (pink line).
Negative control antibody (green line) was rabbit IgG.
MMP9 Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) staining of Human gastric adenocarcinoma tissue using rabbit Anti-MMP9 antibody
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of human gastric adenocarcinoma tissue labeling MMP9 with unpurified ab76003 at a dilution of 1/100.
Perform heat mediated antigen retrieval before commencing with IHC staining protocol.
Unpurified ab76003 staining MMP9 in U87-MG cells treated with domoic acid (ab120338), by ICC/IF. Increase of MMP9 expression correlates with increased concentration of domoic acid, as described in literature.
The cells were incubated at 37°C for 6h in media containing different concentrations of ab120338 (domoic acid) in DMSO, fixed with 4% formaldehyde for 10 minutes at room temperature and blocked with PBS containing 10% goat serum, 0.3 M glycine, 1% BSA and 0.1% tween for 2h at room temperature. Staining of the treated cells with unpurified ab76003 (1/200) dilution was performed overnight at 4°C in PBS containing 1% BSA and 0.1% tween. A DyLight® 488 anti-rabbit polyclonal antibody (Goat Anti-Rabbit IgG H&L (DyLight® 488) preadsorbed ab96899) at 1/250 dilution was used as the secondary antibody. Nuclei were counterstained with DAPI and are shown in blue.
We have systematically measured KD (the equilibrium dissociation constant between the antibody and its antigen), of more than 840 recombinant antibodies to assess not only their individual KD values but also to see the average affinity of antibody.
Based on the comparison with published literature values for mouse monoclonal antibodies, Recombinant antibodies appear to be on average 1-2 order of magnitude higher affinity.
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of human spleen tissue labeling MMP9 with purified ab76003 at 1/1000. Heat mediated antigen retrieval was performed using Tris/EDTA buffer pH 9. Goat Anti-Rabbit IgG H&L (HRP) ab97051, an HRP-conjugated goat anti-rabbit IgG (H+L) was used as the secondary antibody (1/500).
Negative control using PBS instead of primary antibody (inset).
Counterstained with hematoxylin.
MMP9 Western blot staining using rabbit Anti-MMP9 antibody
Running buffer: MOPS.
Conditions: Denatured/reduced.
This blot was produced using a 4-12% Bis-Tris gel under the MOPS buffer system. The gel was run at 200V for 60 minutes before being transferred onto a nitrocellulose membrane at 30V for 70 minutes. The membrane was then blocked for an hour before being incubated with ab76003 (rabbit-anti MMP9; 1.5 ug/mL) for 48 hours at 4°C. Before imaging, antibody binding was detected using infrared-labeled goat anti-rabbit (green) at 1:10,000 dilutions for 1 hour at room temperature.
All lanes: Western blot - Anti-MMP9 antibody [EP1254] (ab76003) at 1.5 µg/mL
All lanes: Western blot - Recombinant Human MMP9 protein (Proenzyme) (Recombinant Human MMP9 protein (Proenzyme) ab82955) at 0.1 µg
All lanes: Goat anti-rabbit at 1/10000 dilution
Predicted band size: 78 kDa
Observed band size: 89 kDa
MMP9 Western blot staining using rabbit Anti-MMP9 antibody
Western blot: Rabbit Monoclonal[EP1254] to MMP9 76003 staining at 1/1000 dilution, shown in green; Mouse anti GAPDH (Anti-GAPDH antibody [6C5] - Loading Control ab8245) loading control staining at 1/20,000 dilution, shown in magenta. A band was observed at 90 kDa in Wild-type A549 TPA-treated (80nM, 24h) cell lysates with no signal observed at this size in MMP9 knockout A549 TPA-treated (80nM, 24h) cell line. To generate this image, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3pc Milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4°C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit 800CW & Goat anti-Mouse 680RD at 1/20,000 dilution.
All lanes: Western blot - Anti-MMP9 antibody [EP1254] (ab76003) at 1/1000 dilution
Lane 1: Wild-type A549 TPA-treated (80nM, 24h) at 20 µg
Lane 2: Wild-type A549 Vehicle Control TPA (0nM, 24h) at 20 µg
Lanes 3 - 4: Western blot - Human MMP9 knockout A549 cell line (ab286527) at 20 µg
Lane 5: Human Lung at 20 µg
Lane 6: MOLT-4 at 20 µg
All lanes: Goat anti-Rabbit 800CW & Goat anti-Mouse 680RD at 1/20000 dilution
Performed under reducing conditions.
Predicted band size: 78 kDa
Observed band size: 90 kDa
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com